92 related articles for article (PubMed ID: 8248641)
1. [Is it justifiable to use antiplatelet drugs as a universal protection in patients with chronic glomerular damage?].
Duclos J
Rev Med Chil; 1993 Mar; 121(3):286-91. PubMed ID: 8248641
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
3. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
4. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
Donadio JV; Anderson CF; Mitchell JC; Holley KE; Ilstrup DM; Fuster V; Chesebro JH
N Engl J Med; 1984 May; 310(22):1421-6. PubMed ID: 6371535
[TBL] [Abstract][Full Text] [Related]
5. [Current trends in the treatment of chronic glomerulonephritis].
Belovezhdov N; Altŭnkova I; Neshev Kh; Robeva R; Gruev I
Vutr Boles; 1981; 20(5):54-64. PubMed ID: 7324454
[TBL] [Abstract][Full Text] [Related]
6. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
7. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Kawasaki Y; Hosoya M; Takahashi A; Isome M; Tanji M; Suzuki H
Am J Kidney Dis; 2005 Mar; 45(3):510-8. PubMed ID: 15754273
[TBL] [Abstract][Full Text] [Related]
9. [Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
Shvetsov MIu; Medvedeva TIu; Kozlovskaia NL; Miroshnichenko NG; Okonova EB; Shonichev DG; Rudenko TE; Stavrovskaia EV; Plieva OK
Ter Arkh; 2001; 73(6):55-61. PubMed ID: 11521525
[TBL] [Abstract][Full Text] [Related]
10. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
11. Progression of renal failure in patients with compromised renal function is not always present: evaluation of underlying disease.
Rottey S; Vanholder R; De Schoenmakere G; Lameire N
Clin Nephrol; 2000 Jul; 54(1):1-10. PubMed ID: 10939750
[TBL] [Abstract][Full Text] [Related]
12. [Features of a cytokine profile in patients with chronic glomerulonephritis with progressive chronic renal failure].
Koriakova NN; Rozhdestvenskaia ED; Kazantseva SV; Bushueva TV; Valamina IE
Ter Arkh; 2006; 78(5):14-7. PubMed ID: 16889043
[TBL] [Abstract][Full Text] [Related]
13. An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease.
Yorioka N; Kiribayashi K; Naito T; Ogata S; Yokoyama Y; Kyuden Y; Ogawa T; Wada K; Hayashi K; Hirabayashi A
J Nephrol; 2008; 21(2):213-20. PubMed ID: 18446716
[TBL] [Abstract][Full Text] [Related]
14. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
[TBL] [Abstract][Full Text] [Related]
15. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
[TBL] [Abstract][Full Text] [Related]
16. The use of heparin in the treatment of idiopathic rapidly progressive glomerulonephritis.
Suc JM; Durand D; Conte J; Mignon-Conte M; Orfila C; That HT; Duchet JP
Clin Nephrol; 1976 Jan; 5(1):9-13. PubMed ID: 1248188
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R
Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739
[TBL] [Abstract][Full Text] [Related]
18. [The ability of partusisten to improve kidney excretory function in the initial stage of kidney failure in patients with chronic glomerulonephritis].
Skipskiĭ IM; Komandenko MS; Shulutko BI; Zamoskovskaia GA
Ter Arkh; 1991; 63(12):125-7. PubMed ID: 1803590
[TBL] [Abstract][Full Text] [Related]
19. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
[TBL] [Abstract][Full Text] [Related]
20. Chronic renal failure and nephrolithiasis in a solitary kidney: role of intervention.
Goel MC; Ahlawat R; Kumar M; Kapoor R
J Urol; 1997 May; 157(5):1574-7. PubMed ID: 9112479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
